Company Profile
Abeona Therapeutics Stock Price, News & Catalysts
- Ticker:
- ABEO
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
5.94 USD (-0.75%)
Close
Last updated: August 17, 2026
324M USD
Market cap
Why the stock is moving
As of Aug 17, 2026, ABEO closed down 0.75% at $5.94. No new same-company headline was identified in the current news window.
Company overview
Cell and Gene Therapy Company
Abeona Therapeutics develops and commercializes genetic medicines for serious diseases.
ZEVASKYN
ZEVASKYN is an autologous, gene-corrected epidermal sheet therapy for wounds in recessive dystrophic epidermolysis bullosa and provides Abeona with a commercial cell-therapy platform.
ABO-701
ABO-701 is an engineered T-cell program targeting PSMA in solid tumors and uses synthetic immune-receptor technology intended to improve selectivity and activity.
Future catalysts
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Abeona Therapeutics (ABEO)?
Abeona Therapeutics (ABEO) most recently closed at 5.94 USD, a -0.75% move versus the previous session.
What is the market cap of Abeona Therapeutics (ABEO)?
Abeona Therapeutics currently has a market capitalization of 324M USD on BioPharmSignal.
What does Abeona Therapeutics do?
Cell and Gene Therapy Company Abeona Therapeutics develops and commercializes genetic medicines for serious diseases. ZEVASKYN ZEVASKYN is an autologous, gene-corrected epidermal sheet therapy for wounds in recessive dystrophic epidermolysis bullosa and provides Abeona with a commercial cell-therapy platform. ABO-701 ABO-701 is an engineered T-cell program...
On which exchange is ABEO stock listed?
Abeona Therapeutics (ABEO) is associated with NASDAQ, United States, Biopharma.
What is ABO-701?
ABO-701 ABO-701 is an engineered T-cell program targeting PSMA in solid tumors and uses synthetic immune-receptor technology intended to improve selectivity and activity.
Which conditions is Abeona Therapeutics targeting with ABO-701?
Abeona Therapeutics is associated with genetic disease based on its company overview and current catalyst commentary.
What is Cell?
Cell and Gene Therapy Company Abeona Therapeutics develops and commercializes genetic medicines for serious diseases.
What is Gene?
Cell and Gene Therapy Company Abeona Therapeutics develops and commercializes genetic medicines for serious diseases.